A large international trial has found that beta blockers, commonly prescribed after heart attacks, offer no clear benefit for patients with normal heart function post-myocardial infarction. The study revealed increased risks of death and hospitalization among women taking these drugs, prompting a reevaluation of their routine use. The REBOOT trial, involving over 8,500 patients, showed no significant differences in outcomes between those who continued or stopped beta blockers after discharge. Teljes cikk (Euronews.com)